Dihydromyricetin (DHM) and fatty liver markers

What 2 graded rows on dihydromyricetin (dhm) agree on for fatty liver markers, and where they differ. Counted side by side, never averaged.

Consensus finder Rows from the Dihydromyricetin (DHM) page, reviewed Oct 21, 2026 How it decides

What the rows agree on

Each block and row is one graded row from the Dihydromyricetin (DHM) page, with its PubMed record.

Supplement

Dihydromyricetin (DHM) Choose another

2 rows · 115 people

They agree: both rows found an improvement.

No difference

Improved

Each block is one evidence row, sized by how many people it enrolled, with its grade inside.

From the rows

The best-graded row, grade C, is a randomized trial of 60 people (2015) and found an improvement.

The rows run from 55 to 60 people, published from 2015 to 2026: 2 single studies.

2 improved

Grade CLiver enzymes, glucose and lipids in non-alcoholic fatty liver disease · Improved
RCT · n 60 · 2015 · Adults with non-alcoholic fatty liver disease (China)
Two 150 mg capsules twice daily (600 mg/day) · 3 months
Compared with placebo, ALT, AST, GGT, glucose, LDL cholesterol, apolipoprotein B and HOMA-IR fell; within the DHM group TNF-alpha, cytokeratin-18 fragment and FGF21 fell and adiponectin rose.
Row on the Dihydromyricetin (DHM) page · PubMed 26032587 (opens PubMed)
Grade CLiver enzymes, liver stiffness and glucose in fatty liver disease (MASLD) · Improved
RCT · n 55 · 2026 · Adults with metabolic dysfunction-associated steatotic liver disease (Greece); 9 withdrew (2 on DHM, 7 on placebo)
2 tablets twice daily, 150 mg DHM per tablet: 600 mg/day in the full-text methods; the abstract states 300 mg/day · 12 months
Combined ALT and GGT normalization at 12 months was more frequent on the supplement (35% vs 5% per protocol; 32% vs 4% by intention to treat). Liver enzymes, glucose, HbA1c and total and LDL cholesterol fell, and liver stiffness was lower than baseline, only in the supplement group. No drug-related adverse events were reported.
Row on the Dihydromyricetin (DHM) page · PubMed 41612982 (opens PubMed)